Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (581)	10/19/1998 3:14:00 PM
From: Michael Olin	Respond to of 1255

Thanks for refreshing my memory (no pun intended). I do remember when CORX was first mentioned in your press releases and on your website. Was the newspaper cover story published after Lynch's presentation or after the ABC story? I also think that CORX put out a couple of press releases back then about the success of the preliminary studies in Sweden. A colleague of mine had had some discussions with a biochemist who knew of their work, and as it seemed promising, we both bought in back then. I do a lot of consulting work (software) for the large pharmaceuticals and have no illusions about the drug discovery and approval process. I'm in this for the long haul and realize that my investment can just as easily evaporate if the trials are not successful. The traders were looking for a quick spike and didn't get it. I just hope that the huge volume with no real movement does not do any more damage to the stock. -Michael